Romain Desgrippes

Gemcitabine and Paclitaxel Versus Gemcitabine Alone After 5-Fluorouracil, Oxaliplatin, and Irinotecan in Metastatic Pancreatic Adenocarcinoma: A Randomized Phase III PRODIGE 65-UCGI 36-GEMPAX UNICANCER Study

Christelle de la Fouchardière, David Malka, Claire Cropet et al. · Journal of Clinical Oncology · 2024 · 35 citations

Medicine, Oncology, Pharmacology +17

Decreased iron burden in overweight C282Y homozygous women: Putative role of increased hepcidin production

Romain Desgrippes, Fabrice Lainé, Jeff Morçet et al. · Hepatology · 2013 · 22 citations · Full text

Medicine, Endocrinology, Hematology +17

PRODIGE 29-UCGI 26 (NEOPAN): A Phase III Randomized Trial Comparing Chemotherapy With FOLFIRINOX or Gemcitabine in Locally Advanced Pancreatic Carcinoma

Michel Ducreux, Romain Desgrippes, Yves Rinaldi et al. · Journal of Clinical Oncology · 2025 · 22 citations

Medicine, Oncology, Pharmacology +15

FOLFIRINEC: a randomized phase II trial of mFOLFIRINOX vs platinum-etoposide for metastatic neuroendocrine carcinoma of gastroenteropancreatic or unknown origin

Julien Hadoux, Pauline Afchain, Thomas Walter et al. · Digestive and Liver Disease · 2021 · 19 citations · Full text

Medicine, Oncology, Pharmacology +17

Preliminary tolerance analysis of adjuvant chemotherapy in older patients after resection of stage III colon cancer from the PRODIGE 34-FFCD randomized trial

Thomas Aparicio, Olivier Bouché, Pierre-Luc Etienne et al. · Digestive and Liver Disease · 2022 · 19 citations · Full text

Medicine, Geriatric Medicine, Oncology +17